FDA approves olaparib for germline BRCA-mutated metastatic breast cancer

Main|Search|PHGKB

From Genomics & Health Impact Scan Database

This database includes published scientific literature on evidence-based translation of genomic discoveries into improved health care and disease prevention that have a potential impact on population health.

---

• FDA approves olaparib for germline BRCA-mutated metastatic breast cancer  
  FDA, Jan 12, 2018
• The risk of unjustified BRCA testing after the "Angelina Jolie effect": how can we save (laboratory) medicine from the Internet?  
  Lippi Giuseppe et al. Clinical chemistry and laboratory medicine 2017 Jul

more